48 Biomedical Intelligence Contexts
Not raw dataset names. Each layer describes the business, scientific, or operational context analysts need inside the warehouse.
Showing 48 of 48 intelligence context layers.
Drug-target mechanism and bioactivity context
Scientific teams use this context to connect mechanism, target biology, chemistry, assays, and disease evidence.
- Coverage
- 2.5M compounds
- Refresh
- Quarterly
- System label
- Scientific layer • 2.5M compounds • Quarterly
Post-market adverse-event signals and safety reporting context
Regulatory teams use this context to reconstruct product history without parsing authority-specific files.
- Coverage
- 25M+ reports
- Refresh
- Quarterly
- System label
- Regulatory layer • 25M+ reports • Quarterly
Listed patent runway and challenge context
Portfolio and BD teams use this context to model protection runway, challenge pressure, and loss-of-exclusivity timing.
- Coverage
- 15K+ patents
- Refresh
- Monthly
- System label
- IP & Patent layer • 15K+ patents • Monthly
Human protein target biology context
Scientific teams use this context to connect mechanism, target biology, chemistry, assays, and disease evidence.
- Coverage
- 20,370 human proteins
- Refresh
- Quarterly
- System label
- Scientific layer • 20,370 human proteins • Quarterly
Active and historical trial landscape context
Clinical teams use this context to compare activity, geography, sponsors, interventions, and external evidence.
- Coverage
- 519K+ trials
- Refresh
- Weekly
- System label
- Clinical layer • 519K+ trials • Weekly
European authorization and dual-market context
Clinical teams use this context to compare activity, geography, sponsors, interventions, and external evidence.
- Coverage
- 1,500+ products
- Refresh
- Monthly
- System label
- Clinical layer • 1,500+ products • Monthly
Approval pathways, review history, and regulatory status
Regulatory teams use this context to reconstruct product history without parsing authority-specific files.
- Coverage
- 400K+
- Refresh
- Monthly
- System label
- Regulatory layer • 400K+ • Monthly
Label-change history and regulatory event timeline
Regulatory teams use this context to reconstruct product history without parsing authority-specific files.
- Coverage
- 140K+ versions
- Refresh
- Monthly
- System label
- Regulatory layer • 140K+ versions • Monthly
Regulatory exclusivity shield context
Portfolio and BD teams use this context to model protection runway, challenge pressure, and loss-of-exclusivity timing.
- Coverage
- 8K+ exclusivity entries
- Refresh
- Monthly
- System label
- IP & Patent layer • 8K+ exclusivity entries • Monthly
Risk-management requirements and safety-burden context
Regulatory teams use this context to reconstruct product history without parsing authority-specific files.
- Coverage
- 400+ programs
- Refresh
- Monthly
- System label
- Regulatory layer • 400+ programs • Monthly
Current prescribing context, warnings, indications, and dosing
Regulatory teams use this context to reconstruct product history without parsing authority-specific files.
- Coverage
- 54K+ active labels
- Refresh
- Weekly
- System label
- Regulatory layer • 54K+ active labels • Weekly
Medicare pharmacy-channel spend and exposure context
Market access teams use this context to quantify spend, exposure, pricing pressure, and reimbursement mechanics.
- Coverage
- 5K+ drugs
- Refresh
- Annual
- System label
- Financial & Market Access layer • 5K+ drugs • Annual
Research funding momentum and grant linkage context
Clinical teams use this context to compare activity, geography, sponsors, interventions, and external evidence.
- Coverage
- 1.27M grants
- Refresh
- Annual
- System label
- Clinical layer • 1.27M grants • Annual
Biomedical literature evidence context
Evidence teams use this context to connect publications, grants, authors, MeSH topics, and full-text source lineage.
- Coverage
- 10.2M papers
- Refresh
- Monthly
- System label
- Literature layer • 10.2M papers • Monthly
Retail-to-medical billing bridge context
Market access teams use this context to quantify spend, exposure, pricing pressure, and reimbursement mechanics.
- Coverage
- 35K+ crosswalk records
- Refresh
- Annual
- System label
- Financial & Market Access layer • 35K+ crosswalk records • Annual
Negotiated price, payment year, and IRA exposure context
Market access teams use this context to quantify spend, exposure, pricing pressure, and reimbursement mechanics.
- Coverage
- 25+ negotiated drugs
- Refresh
- Annual
- System label
- Financial & Market Access layer • 25+ negotiated drugs • Annual
Product labeling, clinical identity, and substance mappings
Regulatory teams use this context to reconstruct product history without parsing authority-specific files.
- Coverage
- 158K+ labels
- Refresh
- Weekly
- System label
- Regulatory layer • 158K+ labels • Weekly
Reporter, patient, and case-demographic safety context
Safety teams use this context to triage signals with case, reaction, outcome, and label coverage already joined.
- Coverage
- 25M+ cases
- Refresh
- Quarterly
- System label
- Safety & Pharmacovigilance layer • 25M+ cases • Quarterly
Drug-event disproportionality and label-coverage context
Safety teams use this context to triage signals with case, reaction, outcome, and label coverage already joined.
- Coverage
- 60M+ drug-reaction pairs
- Refresh
- Quarterly
- System label
- Safety & Pharmacovigilance layer • 60M+ drug-reaction pairs • Quarterly
Biologic competition, biosimilar status, and IRA timing
Regulatory teams use this context to reconstruct product history without parsing authority-specific files.
- Coverage
- 4K+ products
- Refresh
- Monthly
- System label
- Regulatory layer • 4K+ products • Monthly
Small-molecule approval, patent, exclusivity, and IRA timing
Regulatory teams use this context to reconstruct product history without parsing authority-specific files.
- Coverage
- 40K+ products
- Refresh
- Monthly
- System label
- Regulatory layer • 40K+ products • Monthly
Physician-administered drug spend and HCPCS exposure context
Market access teams use this context to quantify spend, exposure, pricing pressure, and reimbursement mechanics.
- Coverage
- 1K+ HCPCS codes
- Refresh
- Annual
- System label
- Financial & Market Access layer • 1K+ HCPCS codes • Annual
Disease topic hierarchy and synonym context
Strategy teams use this context to normalize indications, rare diseases, synonyms, and cross-ontology disease families.
- Coverage
- 31K descriptors
- Refresh
- Annual
- System label
- Disease & Ontology layer • 31K descriptors • Annual
Cross-ontology disease mapping context
Strategy teams use this context to normalize indications, rare diseases, synonyms, and cross-ontology disease families.
- Coverage
- 25K+ terms
- Refresh
- Quarterly
- System label
- Disease & Ontology layer • 25K+ terms • Quarterly
Longitudinal research funding history
Clinical teams use this context to compare activity, geography, sponsors, interventions, and external evidence.
- Coverage
- 1.1M grants
- Refresh
- Annual
- System label
- Clinical layer • 1.1M grants • Annual
Target-disease evidence and druggability context
Strategy teams use this context to normalize indications, rare diseases, synonyms, and cross-ontology disease families.
- Coverage
- 7.5M target-disease associations
- Refresh
- Quarterly
- System label
- Disease & Ontology layer • 7.5M target-disease associations • Quarterly
Physician-industry relationship and payment context
Market access teams use this context to quantify spend, exposure, pricing pressure, and reimbursement mechanics.
- Coverage
- 16M+ payment records
- Refresh
- Annual
- System label
- Financial & Market Access layer • 16M+ payment records • Annual
Research organization identity and hierarchy context
Data teams use this context as the controlled identity layer for joins across the estate.
- Coverage
- 135K+ organizations
- Refresh
- Annual
- System label
- Identity & Registry layer • 135K+ organizations • Annual
Patent family, assignee, and citation context
Portfolio and BD teams use this context to model protection runway, challenge pressure, and loss-of-exclusivity timing.
- Coverage
- 8M+ patents
- Refresh
- Quarterly
- System label
- IP & Patent layer • 8M+ patents • Quarterly
Outpatient payment policy and rate context
Market access teams use this context to quantify spend, exposure, pricing pressure, and reimbursement mechanics.
- Coverage
- Outpatient payment reference
- Refresh
- Annual
- System label
- Financial & Market Access layer • Outpatient payment reference • Annual
Disease classification and crosswalk context
Strategy teams use this context to normalize indications, rare diseases, synonyms, and cross-ontology disease families.
- Coverage
- 10K+ disease terms
- Refresh
- Annual
- System label
- Disease & Ontology layer • 10K+ disease terms • Annual
Packaged product identity and commercial code context
Regulatory teams use this context to reconstruct product history without parsing authority-specific files.
- Coverage
- 800K+ NDCs
- Refresh
- Monthly
- System label
- Regulatory layer • 800K+ NDCs • Monthly
Human gene identity and approved symbol context
Data teams use this context as the controlled identity layer for joins across the estate.
- Coverage
- 43K+ genes
- Refresh
- Monthly
- System label
- Identity & Registry layer • 43K+ genes • Monthly
State Medicaid spend and unit-cost context
Market access teams use this context to quantify spend, exposure, pricing pressure, and reimbursement mechanics.
- Coverage
- 3K+ drugs
- Refresh
- Annual
- System label
- Financial & Market Access layer • 3K+ drugs • Annual
Physician-administered pricing trend context
Market access teams use this context to quantify spend, exposure, pricing pressure, and reimbursement mechanics.
- Coverage
- Quarterly updates
- Refresh
- Quarterly
- System label
- Financial & Market Access layer • Quarterly updates • Quarterly
Chemical concept classification context
Strategy teams use this context to normalize indications, rare diseases, synonyms, and cross-ontology disease families.
- Coverage
- 900K+ chemicals
- Refresh
- Annual
- System label
- Disease & Ontology layer • 900K+ chemicals • Annual
Pharmacy acquisition cost and real-world price context
Market access teams use this context to quantify spend, exposure, pricing pressure, and reimbursement mechanics.
- Coverage
- Weekly pharmacy acquisition costs
- Refresh
- Weekly
- System label
- Financial & Market Access layer • Weekly pharmacy acquisition costs • Weekly
Provider identity, specialty, and organization context
Data teams use this context as the controlled identity layer for joins across the estate.
- Coverage
- 7M+ providers
- Refresh
- Monthly
- System label
- Identity & Registry layer • 7M+ providers • Monthly
Rare disease ontology and hierarchy context
Strategy teams use this context to normalize indications, rare diseases, synonyms, and cross-ontology disease families.
- Coverage
- 15K+ ontology terms
- Refresh
- Annual
- System label
- Disease & Ontology layer • 15K+ ontology terms • Annual
Curated rare disease gene association context
Strategy teams use this context to normalize indications, rare diseases, synonyms, and cross-ontology disease families.
- Coverage
- 8K+ gene associations
- Refresh
- Annual
- System label
- Disease & Ontology layer • 8K+ gene associations • Annual
Rare disease prevalence and gene-association context
Strategy teams use this context to normalize indications, rare diseases, synonyms, and cross-ontology disease families.
- Coverage
- 11K+ rare diseases
- Refresh
- Annual
- System label
- Disease & Ontology layer • 11K+ rare diseases • Annual
Protein interaction network context
Scientific teams use this context to connect mechanism, target biology, chemistry, assays, and disease evidence.
- Coverage
- 13M+ protein-protein interactions
- Refresh
- Quarterly
- System label
- Scientific layer • 13M+ protein-protein interactions • Quarterly
Assay outcome and target-validation context
Scientific teams use this context to connect mechanism, target biology, chemistry, assays, and disease evidence.
- Coverage
- 1M+ assays
- Refresh
- Quarterly
- System label
- Scientific layer • 1M+ assays • Quarterly
Chemical structure and compound identity context
Scientific teams use this context to connect mechanism, target biology, chemistry, assays, and disease evidence.
- Coverage
- 100M+ compounds
- Refresh
- Quarterly
- System label
- Scientific layer • 100M+ compounds • Quarterly
Full-text evidence and RAG-ready context
Evidence teams use this context to connect publications, grants, authors, MeSH topics, and full-text source lineage.
- Coverage
- 3.8M full-text papers
- Refresh
- Monthly
- System label
- Literature layer • 3.8M full-text papers • Monthly
Clinical drug naming and RxCUI identity context
Data teams use this context as the controlled identity layer for joins across the estate.
- Coverage
- 200K+ concepts
- Refresh
- Monthly
- System label
- Identity & Registry layer • 200K+ concepts • Monthly
Medical language and terminology crosswalk context
Data teams use this context as the controlled identity layer for joins across the estate.
- Coverage
- 3M+ concepts
- Refresh
- Annual
- System label
- Identity & Registry layer • 3M+ concepts • Annual
Chemical identity cross-reference context
Data teams use this context as the controlled identity layer for joins across the estate.
- Coverage
- 200M+ cross-references
- Refresh
- Monthly
- System label
- Identity & Registry layer • 200M+ cross-references • Monthly